You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

CNS-BCL

Showing 1 - 25 of 1,150
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

B Cell Malignancies Trial in Beijing, Shenzhen, Haikou (Universal CD19-specific CAR gene-engineered T cells)

Recruiting
  • B Cell Malignancies
  • Universal CD19-specific CAR gene-engineered T cells
  • Beijing, Beijing, China
  • +2 more
Aug 8, 2023

Predict CNS Involvement in Diffuse Large B-Cell Lymphoma:Danish

Completed
  • Diffuse Large B Cell Lymphoma
  • +2 more
    • (no location specified)
    Dec 13, 2021

    Primary Diffuse Large B-cell Lymphoma of the CNS (CNS), Aggressive B-cell Lymphoma With Secondary Involvement of the CNS Trial

    Suspended
    • Primary Diffuse Large B-cell Lymphoma of the Central Nervous System (CNS)
    • Aggressive B-cell Lymphoma With Secondary Involvement of the CNS
    • Bethesda, Maryland
      National Institutes of Health Clinical Center
    Jul 6, 2022

    Advanced Breast Cancer Trial in Changsha (TQB3909 tablets)

    Recruiting
    • Advanced Breast Cancer
    • TQB3909 tablets
    • Changsha, Hunan, China
      Hunan Cancer Hospital
    Mar 16, 2023

    Burkitt Lymphoma, High-grade B-cell Lymphoma, T-cell/Histocyte-rich Large B-cell Lymphoma Trial run by the NCI (Rituximab,

    Suspended
    • Burkitt Lymphoma
    • +4 more
    • Rituximab
    • +6 more
    • Bethesda, Maryland
      National Institutes of Health Clinical Center
    Feb 2, 2023

    B Cell Lymphoma (BCL) Trial in Shenzhen (4SCAR19 and 4SCAR20/22/70/PSMA/13/79b/GD2)

    Recruiting
    • B Cell Lymphoma (BCL)
    • 4SCAR19 and 4SCAR20/22/70/PSMA/13/79b/GD2
    • Shenzhen, Guangdong, China
    • +2 more
    Jun 10, 2020

    Chronic Lymphocytic Leukemia (CLL), Small Lymphocytic Lymphoma (SLL), Diffuse Large B Cell Lymphoma (DLBCL) Trial in Manchester,

    Recruiting
    • Chronic Lymphocytic Leukemia (CLL)
    • +7 more
    • Manchester, United Kingdom
    • +2 more
    Aug 11, 2022

    Acute Myeloid Leukemia Trial in Nanjing (Venclexta 100 MG Oral Tablet)

    Recruiting
    • Acute Myeloid Leukemia
    • Venclexta 100 MG Oral Tablet
    • Nanjing, Jiangsu, China
      The First Affiliated Hospital with Nanjing Medical University
    Jun 11, 2023

    Idiopathic Pulmonary Fibrosis Trial in Birmingham (Venetoclax)

    Not yet recruiting
    • Idiopathic Pulmonary Fibrosis
    • Birmingham, Alabama
      A. Brent Carter
    Aug 3, 2023

    Follicular Lymphoma, Grade 1, Follicular Lymphoma, Grade 2, Follicular Lymphoma Grade 3A Trial in Italy (OFATUMUMAB)

    Completed
    • Follicular Lymphoma, Grade 1
    • +2 more
    • Alessandria, AL, Italy
    • +26 more
    Jun 16, 2022

    Advanced Malignant Tumor Trial in Nanjing, Tianjin (TQB3909 Tablets)

    Recruiting
    • Advanced Malignant Tumor
    • TQB3909 Tablets
    • Nanjing, Jiangsu, China
    • +1 more
    Mar 3, 2022

    High Grade Serous Carcinoma, Triple Negative Breast Cancer, Ovarian Cancer Trial (Olaparib tablet, Navitoclax)

    Recruiting
    • High Grade Serous Carcinoma
    • +2 more
    • Toronto, Ontario, Canada
    • +2 more
    Nov 28, 2022

    Metastatic Malignant Solid Tumor, Refractory Malignant Solid Tumor, Unresectable Malignant Solid Tumor Trial in Boston

    Active, not recruiting
    • Metastatic Malignant Solid Neoplasm
    • +2 more
    • Biopsy
    • +6 more
    • Boston, Massachusetts
    • +1 more
    Nov 8, 2022

    Acute Myeloid Leukemia Trial in Marseille, Nice (Pharmacokinetic sampling, Vital status determination, Toxicity assessments)

    Not yet recruiting
    • Acute Myeloid Leukemia
    • Pharmacokinetic sampling
    • +3 more
    • Marseille, France
    • +1 more
    Sep 6, 2023

    Acute Myeloid Leukemia (AML) Trial in Birmingham, San Francisco, New York (ZN-d5 ZN-c3, ZN-c3)

    Recruiting
    • Acute Myeloid Leukemia (AML)
    • Birmingham, Alabama
    • +2 more
    Jan 3, 2023

    Lymphoma Trial in United States (carmustine, cytarabine, etoposide)

    Active, not recruiting
    • Lymphoma
    • Anchorage, Alaska
    • +125 more
    Aug 16, 2021

    Clinical Significance of Occult Central Nervous System

    Recruiting
    • Acute Lymphoblastic Leukemia
    • cerebrospinal fluids exams
    • Roma, RM, Italy
      Tor Vergata University
    Mar 17, 2023

    Non-hodgkin Lymphoma, B Cell Trial in Switzerland (ctDNA detection)

    Not yet recruiting
    • Non-hodgkin Lymphoma, B Cell
    • ctDNA detection
    • Aarau, Switzerland
    • +12 more
    Oct 18, 2023

    Acute Myeloid Leukemia Trial in Worldwide (MBG453, Venetoclax, Azacitidine)

    Active, not recruiting
    • Acute Myeloid Leukemia
    • Birmingham, Alabama
    • +27 more
    Jan 20, 2023

    Blastoid Variant Mantle Cell Lymphoma, Mantle Cell Lymphoma, Pleomorphic Variant Mantle Cell Lymphoma Trial in Duarte

    Not yet recruiting
    • Blastoid Variant Mantle Cell Lymphoma
    • +2 more
    • Biopsy
    • +8 more
    • Duarte, California
      City of Hope Medical Center
    May 15, 2023

    Recurrent Mantle Cell Lymphoma, Refractory Mantle Cell Lymphoma Trial in Rochester (procedure, drug, biological)

    Not yet recruiting
    • Recurrent Mantle Cell Lymphoma
    • Refractory Mantle Cell Lymphoma
    • Biopsy
    • +10 more
    • Rochester, Minnesota
      Mayo Clinic in Rochester
    Jun 9, 2023

    Endogenous Analgesia in Patients With Chronic Knee Pain

    Recruiting
    • Chronic Pain
    • +3 more
      • Pittsburgh, Pennsylvania
        UPMC Pain Medicine at Centre Commons
      Jan 9, 2023

      Clinical Stage III Cutaneous Melanoma AJCC v8, Clinical Stage IV Cutaneous Melanoma AJCC v8, Malignant Solid Tumor Trial in

      Active, not recruiting
      • Clinical Stage III Cutaneous Melanoma AJCC v8
      • +4 more
      • Phoenix, Arizona
      • +48 more
      Jan 3, 2023

      HLH Trial in Beijing (Teniposide)

      Recruiting
      • HLH
      • Beijing, China
        Zhao Wang
      Sep 15, 2023

      Prostate Cancer Trial in Herlev (Bcl-Xl_42-CAF09b vaccine)

      Completed
      • Prostate Cancer
      • Bcl-Xl_42-CAF09b vaccine
      • Herlev, Denmark
        Herlev Hospital
      Jan 10, 2022